Pink Bikini Strong Formula capsules
Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and phenolphthalein.
Every FDA drug recall initiated in 2015, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,733 recalls, newest first.
Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and phenolphthalein.
Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Lack of assurance of sterility
Cross Contamination With Other Products: Potential cross-contamination of cephalosporin.
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.